Search

Displaying results 6071 - 6080 of 10000 in total
  1. Drug

    PPL-100

    go.drugbank.com/drugs/DB05961
    Investigational

  2. Drug

    Managlinat dialanetil

    go.drugbank.com/drugs/DB05518
    Investigational

    CS-917 is a novel inhibitor of fructose 1,6-bisphphosphatase (FBPase) which is one of the rate-limiting enzymes of gluconeogenesis.

  3. Drug

    Cabamiquine

    go.drugbank.com/drugs/DB21477
    Investigational

    Cabamiquine is under investigation in clinical trial NCT05974267 (Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium … Cabamiquine is a small molecule drug.

  4. Drug

    Phelimin

    go.drugbank.com/drugs/DB18332
    Experimental

    [L48151] It is under investigation for the treatment of hyperphenylalaninemia. … Phelemin (PHE-MIP) is a methacrylic acid-based copolymer purified to bind to L-phenylalanine and L-phenylalanine-containing peptides.

  5. Drug

    Fentonium

    go.drugbank.com/drugs/DB08978
    ApprovedWithdrawn

    Fentonium is an atropine derivative.

    Categories: Drugs for Functional Gastrointestinal Disorders
  6. Drug

    DNB-001

    go.drugbank.com/drugs/DB05757
    Investigational

    DNB-001 is a first-in-class oral therapy with dual mechanism of action, which is initially being developed for the treatment of glaucoma. … In preclinical animal models, DNB-001 has demonstrated potent IOP- lowering effects as well as neuroprotective effects on the optic nerve.

  7. Drug

    Azelnidipine

    go.drugbank.com/drugs/DB09230
    Investigational

    It is currently being studied for post-ischemic stroke management [L1380]. … Azelnidipine is a dihydropyridine calcium channel blocker. It is marketed by Daiichi-Sankyo pharmaceuticals, Inc. in Japan.

  8. Drug

    Neisseria meningitidis serogroup b nada protein antigen

    go.drugbank.com/drugs/DB10785
    ApprovedInvestigational

    Mixtures: BEXSERO 0,5 ML İM ENJEKSİYONLUK SÜSPANSİYON İÇEREN KULLANIMA HAZIR ENJEKTÖR, 1 ADET 2 İĞNELİ, BEXSERO 0,5 ML İM ENJEKSİYONLUK SÜSPANSİYON İÇEREN KULLANIMA HAZIR ENJEKTÖR, 1 ADET İĞNESİZ
  9. Drug

    Enviomycin

    go.drugbank.com/drugs/DB08993
    Experimental

    Cyclic basic peptide related to viomycin. … It is isolated from an induced mutant of Streptomyces griseoverticillatus var. tuberacticus and acts as an antitubercular agent with less ototoxicity than tuberactinomycin.

    Categories: Antiinfectives for Systemic Use, Drugs for Treatment of TuberculosisSynonyms: Tuberactinomycin N
  10. Drug

    Benzimate

    go.drugbank.com/drugs/DB05170
    Experimental

    It is currently under investigation by AmpliMed and is in phase I of clinical trial. … The anti-cancer and anti-viral activity of the benzimidazoles was originally investigated by the Proctor & Gamble Company beginning in the 1990's.